Form C - Offering Statement:
SEC Accession No. 0002032967-24-000001
Filing Date
2024-09-13
Accepted
2024-09-13 16:36:26
Documents
12

Document Format Files

Seq Description Document Type Size
1 primary_doc.html C  
1 primary_doc.xml C 11219
2 offering_statement.pdf EX-99 271504
3 exhibit_a1.pdf EX-99 216234
4 exhibit_a2.pdf EX-99 216972
5 exhibit_b.pdf EX-99 2020048
6 exhibit_c.pdf EX-99 120214
7 exhibit_d.pdf EX-99 234423
8 exhibit_e.pdf EX-99 219815
9 exhibit_f.pdf EX-99 1325023
10 exhibit_g.pdf EX-99 291019
11 exhibit_h.pdf EX-99 334802
12 exhibit_i.pdf EX-99 107418
  Complete submission text file 0002032967-24-000001.txt   7325897
Mailing Address 2229 WEST MILLS DRIVE ORANGE CA 92868
Business Address 2229 WEST MILLS DRIVE ORANGE CA 92868 (714) 585-7485
Coronavax Inc. (Filer) CIK: 0002032967 (see all company filings)

EIN.: 862258365 | State of Incorp.: DE | Fiscal Year End: 1231
Type: C | Act: 33 | File No.: 020-34774 | Film No.: 241298269